Recombinant Anti-PD-L1 Antibody, Rabbit Monoclonal

RRID Number: AB_2860079
EliteRmab®, manufactured by recombinant technology
1/1
Price:
Size:
Number:

Recombinant Anti-PD-L1 Antibody, Rabbit Monoclonal 产品信息

产品名称
Recombinant Anti-PD-L1 Antibody, Rabbit Monoclonal
经验证的应用
ELISA,IHC-P
交叉反应
Reacts with: Human
特异性
Human PD-L1
No cross-reactivity in ELISA with
Human B7-1
Human B7-2
Mouse B7-H1
Non-blocking
This B7-H1/PD-L1 antibody can not block the binding of recombinant PD1 (10377-H03H) to its recombinant ligand B7-H1/PD-L1 (10084-H02H).
免疫原
Recombinant Human PD-L1 / B7-H1 / CD274 protein (Catalog#10084-H08H)
制备方法
This antibody was obtained from a rabbit immunized with purified, recombinant Human PD-L1 / B7-H1 / CD274 (rh PD-L1 / B7-H1 / CD274; Catalog#10084-H08H; NP_054862.1; Met 1-Thr 239).
来源
Monoclonal Rabbit IgG Clone #015
纯化
Protein A
缓冲液
0.2 μm filtered solution in PBS
偶联物
Unconjugated
状态
Liquid
运输方式
This antibody is shipped as liquid solution at ambient temperature. Upon receipt, store it immediately at the temperature recommended below.
储存条件
This antibody can be stored at 2℃-8℃ for one month without detectable loss of activity. Antibody products are stable for twelve months from date of receipt when stored at -20℃ to -80℃. Preservative-Free. Avoid repeated freeze-thaw cycles.

Recombinant Anti-PD-L1 Antibody, Rabbit Monoclonal 经验证的应用

应用 推荐稀释比/用量
ELISA 1:5000-1:10000
IHC-P 1:100-1:500
Please Note: Optimal concentrations/dilutions should be determined by the end user.

Recombinant Anti-PD-L1 Antibody, Rabbit Monoclonal 图片

Immunochemical staining of human B7H1 in human placenta with rabbit monoclonal antibody (1:200, formalin-fixed paraffin embedded sections). Positive staining was localized to trophoblast.

Recombinant Anti-PD-L1 Antibody, Rabbit Monoclonal: 别称

Anti-B7-H Antibody; Anti-B7-H1 Antibody; Anti-B7H1 Antibody; Anti-PD-L1 Antibody; Anti-PDCD1L1 Antibody; Anti-PDCD1LG1 Antibody; Anti-PDL1 Antibody

PD-L1 背景信息

Programmed death-1 ligand-1 (PD-L1, CD274, B7-H1) has been identified as the ligand for the immunoinhibitory receptor programmed death-1(PD1/PDCD1) and has been demonstrated to play a role in the regulation of immune responses and peripheral tolerance. PD-L1/B7-H1 is a member of the growing B7 family of immune molecules and this protein contains one V-like and one C-like Ig domain within the extracellular domain, and together with PD-L2, are two ligands for PD1 which belongs to the CD28/CTLA4 family expressed on activated lymphoid cells. By binding to PD1 on activated T-cells and B-cells, PD-L1 may inhibit ongoing T-cell responses by inducing apoptosis and arresting cell-cycle progression. Accordingly, it leads to growth of immunogenic tumor growth by increasing apoptosis of antigen specific T cells and may contribute to immune evasion by cancers. PD-L1 thus is regarded as promising therapeutic target for human autoimmune disease and malignant cancers.
全称
CD274 molecule
研究领域
参考文献
  • Iwai Y, et al. (2002) Involvement of PD-L1 on tumor cells in the escape from host immune system and tumor immunotherapy by PD-L1 blockade. Proc Natl Acad Sci U S A. 99(19): 12293-7.
  • Ghebeh H, et al. (2006) The B7-H1 (PD-L1) T lymphocyte-inhibitory molecule is expressed in breast cancer patients with infiltrating ductal carcinoma: correlation with important high-risk prognostic factors. Neoplasia. 8(3): 190-8.
  • Salih HR, et al. (2006) The role of leukemia-derived B7-H1 (PD-L1) in tumor-T-cell interactions in humans. Exp Hematol. 34(7): 888-94.
  • Wilcox RA, et al. (2009) B7-H1 (PD-L1, CD274) suppresses host immunity in T-cell lymphoproliferative disorders. Blood. 114(10): 2149-58.
  • Ruggiero A, et al. (2009) Crystal structure of PD-L1, a ribosome inactivating protein from Phytolacca dioica L. leaves with the property to induce DNA cleavage. Biopolymers. 91(12): 1135-42.
  • PD-L1 expression is characteristic of a subset of aggressive B-cell lymphomas and virus-associated malignancies
    Author
    BJ Chen, B Chapuy, J Ouyang, HH Sun…
    Year
    2013
    Journal
    Clinical Cancer research
    Application
    binding
  • PD-L1 Expression Is Increased in a Subset of Basal Type Breast Cancer Cells
    Author
    Soliman, H;Khalil, F;Antonia, S;
    Year
    2014
    Journal
    PLoS ONE
    Application
    IHC
  • Magnitude of PD-1, PD-L1 and T Lymphocyte Expression on Tissue from Castration-Resistant Prostate Adenocarcinoma: An Exploratory Analysis
    Author
    Massari, F;Ciccarese, C;Caliò, A;Munari, E;Cima, L;Porcaro, AB;Novella, G;Artibani, W;Sava, T;Eccher, A;Ghimenton, C;Bertoldo, F;Scarpa, A;Sperandio, N;Porta, C;Bronte, V;Chilosi, M;Bogina, G;Zamboni, G;Tortora, G;Samaratunga, H;Martignoni, G;Brunelli, M;
    Year
    2015
    Journal
    Target Oncol
    Application
    IHC
  • PD-L1 Antibodies to Its Cytoplasmic Domain Most Clearly Delineate Cell Membranes in Immunohistochemical Staining of Tumor Cells
    Author
    Mahoney, KM;Sun, H;Liao, X;Hua, P;Callea, M;Greenfield, EA;Hodi, FS;Sharpe, AH;Signoretti, S;Rodig, SJ;Freeman, GJ;
    Year
    2015
    Journal
    Cancer Immunol Res
    Application
    IHC
  • Developing a LANCE TR-FRET Assay for Screening PD-1 and PD-L1 Binding Inhibitors
    Author
    Hinterneder, J;Hopkinton, MA;
    Year
    2017
    Journal
    Product
    Application
    control assay
  • Gene signature driving invasive mucinous adenocarcinoma of the lung
    Author
    Guo, M;Tomoshige, K;Meister, M;Muley, T;Fukazawa, T;Tsuchiya, T;Karns, R;Warth, A;Fink-Baldauf, IM;Nagayasu, T;Naomoto, Y;Xu, Y;Mall, MA;Maeda, Y;
    Year
    2017
    Journal
    EMBO Mol Med
    Application
    WB
添加购物车成功! 添加购物车失败!请再次尝试 正在更新购物车,请稍后 U.S.A.